Randomized clinical trial of intravenous valproate (Orifil) and dexamethasone in patients with migraine disorder

Iranian Journal of Medical Sciences

Volumn 38, Issue SUPPL 2, 2013, Pages 150-155

  Foroughipour, Mohsen ^a   Ghandehari, Kavian ^a   Khazaei, Mojtaba ^a   Ahmadi, Fahimeh ^a   Shariatinezhad, Keyvan ^a   Ghandehari, Kosar ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dexamethasone; Migraine disorders; Valproic acid

Indexed keywords

DEXAMETHASONE; ORIFIL; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MIGRAINE; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

EID: 84880116261     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Leone M, Vila C, McGown C. Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study. Expert Rev Neurother. 2010;10:1399-408. doi: 10.1586/ern.10.119. PubMed PMID: 20819011.
2. Ferrari MD, Färkkilä M, Reuter U, Pilgrim A, Davis C, Krauss M, et al. Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-ofconcept trial. Cephalalgia. 2010;30:1170-8. doi: 10.1177/0333102410375512. PubMed PMID: 20855362.
3. Connor KM, Shapiro RE, Diener HC, Lucas S, Kost J, Fan X, et al. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology. 2009;73:970-7. doi: 10.1212/WNL.0b013e3181b87942. PubMed PMID: 19770473; PubMed Central PMCID: PMC2754336.
4. Dahlöf CG, Hauge AW, Olesen J. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a doubleblind, parallel-group, randomized study. Cephalalgia. 2009;29:7-16. doi: 10.1111/j.1468-2982.2009.01975.x. PubMed PMID: 19723121.
5. Krymchantowski AV, Barbosa JS. Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug. Arq Neuropsiquiatr. 2001;59:708-11. doi: 10.1590/S0004-282X2001000500010. PubMed PMID: 11593269.
6. Thomaides T, Karapanayiotides T, Kerezoudi E, Avramidis T, Haeropoulos C, Zoukos Y, et al. Intravenous valproate aborts glyceryl trinitrate-induced migraine attacks: a clinical and quantitative EEG study. Cephalalgia. 2008;28:250-6. doi: 10.1111/j.1468-2982.2007.01513.x. PubMed PMID: 18201252.
7. Avraham SB, Har-Gil M, Watemberg N. Acute confusional migraine in an adolescent: response to intravenous valproate. Pediatrics. 2010;125:e956-9. doi: 10.1542/peds.2009-2717. PubMed PMID: 20211950.
8. Shahien R, Saleh SA, Bowirrat A. Intravenous sodium valproate aborts migraine headaches rapidly. Acta Neurol Scand. 2011;123:257-65. doi: 10.1111/j.1600-0404.2010.01394.x. PubMed PMID: 20569223.
9. Norton J. Use of intravenous valproate sodium in status migraine. Headache. 2000;40:755-7. doi: 10.1046/j.1526-4610.2000.00133.x. PubMed PMID: 11091297.
10. Frazee LA, Foraker KC. Use of intravenous valproic acid for acute migraine. Ann Pharmacother. 2008;42:403-7. doi: 10.1345/aph.1K531. PubMed PMID: 18303140.
11. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24:9-160. PubMed PMID: 14979299.
12. Krusz JC, Cagle J, Scott LV. Intravenous Valproate for Treatment of Status Migrainosus in the Headache Clinic: A Retrospective Look. Headache&Pain. 2006;17:121-8.
13. McCaffery M, Beebe A. Pain: Clinical manual for nursing practice. 1st ed. Baltimore: Mosby Company; 1993. p. 122.
14. Innes GD, Macphail I, Dillon EC, Metcalfe C, Gao M. Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial. CJEM. 1999;1:26-33. PubMed PMID: 17659098.
15. Askari H, Zaidi M. Pulse IV steroid and IV valproate combination therapy for sustained relief of chronic, treatment refractory headaches in patients with psychiatric disorders. Neurology. 2010;74:575.
16. Krusz JC. Intravenous valproate sodium in the treatment of migraine headaches in the headache clinic. Headache. 2001;12:39-41.
17. Waberzinek G, Marková J, Mastík J. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine. Neuro Endocrinol Lett. 2007;28:59-64. PubMed PMID: 17277725.
18. Reiter PD, Nickisch J, Merritt G. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine. Headache. 2005;45:899-903. doi: 10.1111/j.1526-4610.2005.05158.x. PubMed PMID: 15985107.
19. Bigal M, Sheftell F, Tepper S, Tepper D, Ho TW, Rapoport A. A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache. 2008;48:1286-93. doi: 10.1111/j.1526-4610.2008.01092.x. PubMed PMID: 19031496.
20. Monzillo PH, Nemoto PH, Costa AR, Sanvito WL. [Acute treatment of migraine in emergency room: comparative study between dexametasone and haloperidol. Preliminary results]. Arq Neuropsiquiatr. 2004;62:513-8. PubMed PMID: 15273854. Portuguese.
21. Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40:720-3. doi: 10.1046/j.1526-4610.2000.00125.x. PubMed PMID: 11091289.
22. Rowe BH, Colman I, Edmonds ML, Blitz S, Walker A, Wiens S. Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache. Headache. 2008;48:333-40. doi: 10.1111/j.1526-4610.2007.00959.x. PubMed PMID: 18047499.
23. Kelly AM, Kerr D, Clooney M. Impact of oral dexamethasone versus placebo after ED treatment of migraine with phenothiazines on the rate of recurrent headache: a randomised controlled trial. Emerg Med J. 2008;25:26-9. doi: 10.1136/emj.2007.052068. PubMed PMID: 18156535.
24. Fiesseler FW, Shih R, Szucs P, Silverman ME, Eskin B, Clement M, et al. Steroids for migraine headaches: a randomized doubleblind, two-armed, placebo-controlled trial. J Emerg Med. 2011;40:463-8. doi: 10.1016/j. jemermed.2009.08.022. PubMed PMID: 19846269.
25. Singh A, Alter HJ, Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? A meta-analysis and systematic review of the literature. Acad Emerg Med. 2008;15:1223-33. doi: 10.1111/j.1553-2712.2008.00283.x. PubMed PMID: 18976336.
26. Friedman BW, Greenwald P, Bania TC, Esses D, Hochberg M, Solorzano C, et al. Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology. 2007;69:2038-44. doi: 10.1212/01. WNL.0000281105.78936.1d. PubMed PMID: 17942818.
27. Saadah HA. Abortive migraine therapy in the office with dexamethasone and prochlorperazine. Headache. 1994;34:366-70. doi: 10.1111/j.1526-4610.1994. hed3406366.x. PubMed PMID: 7928317.
28. Donaldson D, Sundermann R, Jackson R, Bastani A. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebocontrolled randomized clinical trial. Am J Emerg Med. 2008;26:124-30. doi: 10.1016/j. ajem.2007.03.029. PubMed PMID: 18272089.
29. Colman I, Friedman BW, Brown MD, Innes GD, Grafstein E, Roberts TE, et al. Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence. BMJ. 2008;336:1359-61. doi: 10.1136/bmj.39566.806725. BE. PubMed PMID: 18541610; PubMed Central PMCID: PMC2427093.
30. Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41:976-80. doi: 10.1046/j.1526-4610.2001.01191.x. PubMed PMID: 11903525.
31. Ghandehari K. Headaches: Diagnosis and Management. 1st ed. Mashhad: Jahad Daneshgahi Publications; 2000. p. 48.